1,235 Shares in Humana Inc. (NYSE:HUM) Purchased by Team Hewins LLC

Team Hewins LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,235 shares of the insurance provider’s stock, valued at approximately $566,000.

A number of other institutional investors have also added to or reduced their stakes in the business. Rakuten Securities Inc. bought a new position in shares of Humana during the 4th quarter valued at about $25,000. Gradient Investments LLC increased its position in shares of Humana by 200.0% during the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 40 shares during the last quarter. Cetera Trust Company N.A bought a new position in shares of Humana during the 4th quarter valued at about $28,000. Private Wealth Management Group LLC bought a new position in shares of Humana during the 4th quarter valued at about $32,000. Finally, Turtle Creek Wealth Advisors LLC bought a new position in Humana during the 4th quarter worth approximately $55,000. 92.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on HUM shares. Oppenheimer dropped their price objective on Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a report on Thursday, April 25th. TD Cowen lowered their target price on Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a research report on Tuesday, April 2nd. UBS Group lowered their price objective on Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research report on Thursday, April 25th. Wells Fargo & Company decreased their target price on Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Finally, Stephens cut their target price on Humana from $550.00 to $430.00 and set an “overweight” rating on the stock in a research note on Friday, January 26th. Eleven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $426.39.

Humana Stock Performance

Shares of Humana stock traded down $3.33 on Friday, reaching $348.89. 1,241,188 shares of the stock were exchanged, compared to its average volume of 1,922,345. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The business has a fifty day moving average price of $323.46 and a two-hundred day moving average price of $372.57. The firm has a market capitalization of $42.04 billion, a PE ratio of 21.74, a PEG ratio of 2.07 and a beta of 0.50.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The company had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. Humana’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter last year, the business earned $9.38 EPS. As a group, research analysts anticipate that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.01%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.